References
- International agency for research on cancer. Cancer Today: population fact sheets, Asia- India. [cited 2018 Dec 30]. Available from: http://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
- World Health organization. Cancer-Breast cancer. [cited 2019 Jan 2]. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
- Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012;33:7–12.
- Anonymous. Three year report of population based cancer registries 2012–2014. Bangalore, India: Indian Council of Medical Research (ICMR); 2016.
- Agarwal G, Pradeep PV, Aggarwal V, et al. Spectrum of breast cancer in Asian women. World J Surg. 2007;31:1031–1040.
- Thawani V, Mani A, Upmanyu N. Why the Jan Aushadhi Scheme has lost its steam in India? J Pharmacol Pharmacother. 2017;8(3):134–136.
- Mukherjee K. A cost analysis of the Jan Aushadhi scheme in India. Int J Health Policy Manag. 2017 May;6(5):253.
- Essential medicines and health products information portal. A world health organization resource. Introduction to drug utilization research. Chapter 4.2-cost minimization analysis. [cited 2019 Jan 5]. Available from: http://apps.who.int/medicinedocs/en/d/Js4876e/5.2.html#Js4876e.5.2
- Kolasani BP, Malathi DC, Ponnaluri RR. Variation of cost among anti-cancer drugs available in Indian market. J Clin Diagn Res. 2016 Nov;10(11):FC17.
- Shaik R, Muragundi PM. Evaluation of cost disparity among generic medicines in india. Asian J Pharm Clin Res. 2018;11(12):466–468.
- CIMS. [cited 2019 Jan 10]. Available from: http://www.cimsasia.com/india
- Bureau of Pharma PSUs of India (BPPI). PMBJP Products-cost list. [cited 2019 Jan 10]. Available from: http://janaushadhi.gov.in/Data/BPPI-MRP-LIST_11122018.pdf
- Swaminathan S. Consensus document for management of breast cancer. ICMR. 2016;(1):11-28.
- Michaud LB, Espirito JL, Esteva FJ. Breast Cancer. In: DiPiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy A pathophysiologic approach. 7th ed. United States of America: McGraw-Hill Companies, Inc; 2008. p. 2121–2156.
- Sacco JJ, Botten J, Macbeth F, et al. The average body surface area of adult cancer patients in the UK: a multicentre retrospective study. PloS One. 2010 Jan 28;5(1):e8933.
- US Food and Drug Administration (FDA). Approval of generic drugs. In: Generic drugs. Silver Spring, MD: FDA; 2008. cited 2019 Jan 20. Available From: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm127615.pdf.
- Gota V, Patial P. Toward better quality of anticancer generics in India. Indian J Cancer. 2014;51(3):366.
- Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015 cited 2015 Jul 29;13:173. .
- Franchise India. How Pradhan Mantri Janaushadhi Pariyojana is affecting the healthcare industry. [cited 2019 Jun 21]. Available from: https://www.franchiseindia.com/wellness/how-pradhan-mantri-janaushadhi-pariyojana-is-affecting-the-healthcare-industry.11193
- Business Standard. Charticle: how Jan Aushadhi stores are disrupting the Indian pharma market. [cited 2019 Jun 21]. Available from: https://www.business-standard.com/article/companies/charticle-how-jan-aushadhi-stores-are-disrupting-the-indian-pharma-market-119032200265_1.html
- Lopes GD. Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India. Ann Oncol. 2013 Sep 1; 24(suppl_5):v13–6.
- Nagargoje MM, Chaudhary SS, Siddiqui HA, et al. Generic drugs for public health in India: unbranded versus branded generics. MRIMS J Health Sci. 2017;5(2):48–52.
- Bhargava A, Kalantri SP. The crisis in access to essential medicines in India: key issues which call for action. Indian J Med Ethics. 2013;10(2):86–95. Apr-Jun
- Rajpal S, Kumar A, Joe W. Economic burden of cancer in India: evidence from cross-sectional nationally representative household survey, 2014. PloS one. 2018 Feb 26;13(2):e0193320.